Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Ionis Pharmaceuticals Stock News

IONSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$28.38

-0.30-1.05%

At close: -

$29.79

1.414.97%

After Hours: 4:34 PM EDT

Ionis Pharmaceuticals (IONS) Forecast

News

Earnings Ionis Pharmaceuticals (IONS) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest Ionis Pharmaceuticals Stock News | NASDAQ:IONS | Benzinga

Get the latest news on Ionis Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Ionis Pharmaceuticals performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, April 15, 2025

Needham Reiterates Buy on Ionis Pharmaceutica...
Benzinga Newsdesk - 18 hours ago

Tuesday, April 08, 2025

Needham Reiterates Buy on Ionis Pharmaceutica...
Benzinga Newsdesk - Apr 8, 2025, 8:39AM

Monday, April 07, 2025

Drugmaker Ionis Pharmaceuticals Garners Analyst Praise For 'Pipeline Depth'
Vandana Singh - Apr 7, 2025, 2:11PM
This Reddit Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Avi Kapoor - Apr 7, 2025, 11:38AM
HC Wainwright & Co. Initiates Coverage On Ion...
Benzinga Newsdesk - Apr 7, 2025, 7:27AM

Thursday, April 03, 2025

Guggenheim Reiterates Buy on Ionis Pharmaceut...
Benzinga Newsdesk - Apr 3, 2025, 10:26AM

Monday, March 31, 2025

Assessing Ionis Pharmaceuticals: Insights From 8 Financial Analysts
Benzinga Insights - Mar 31, 2025, 10:01AM
Redburn Atlantic Initiates Coverage On Ionis ...
Benzinga Newsdesk - Mar 31, 2025, 9:18AM

Wednesday, March 26, 2025

Ionis Pharmaceuticals Announced That It Has E...
Benzinga Newsdesk - Mar 26, 2025, 7:02AM

Monday, March 24, 2025

JP Morgan Maintains Neutral on Ionis Pharmace...
Benzinga Newsdesk - Mar 24, 2025, 8:47AM

Wednesday, March 12, 2025

Ionis Pharmaceuticals Partners With Japan-Based Ono Pharmaceutical For Rare Blood Disease Drug In Over $800 Million Deal
Vandana Singh - Mar 12, 2025, 9:56AM

Tuesday, March 11, 2025

Ionis, Ono Pharmaceutical Enter License Agree...
Benzinga Newsdesk - Mar 11, 2025, 6:04PM
What Analysts Are Saying About Ionis Pharmaceuticals Stock
Benzinga Insights - Mar 11, 2025, 5:00PM
JP Morgan Maintains Neutral on Ionis Pharmace...
Benzinga Newsdesk - Mar 11, 2025, 10:55AM

Monday, March 10, 2025

Ionis and AstraZeneca Win EU Approval for WAI...
Benzinga Newsdesk - Mar 10, 2025, 7:02AM

Thursday, February 20, 2025

What Analysts Are Saying About Ionis Pharmaceuticals Stock
Benzinga Insights - Feb 20, 2025, 5:03PM
Citigroup Maintains Buy on Ionis Pharmaceutic...
Benzinga Newsdesk - Feb 20, 2025, 1:33PM
RBC Capital Reiterates Outperform on Ionis Ph...
Benzinga Newsdesk - Feb 20, 2025, 11:41AM
BMO Capital Maintains Market Perform on Ionis...
Benzinga Newsdesk - Feb 20, 2025, 9:21AM
Ionis To Present New Donidalorsen Data At AAA...
Benzinga Newsdesk - Feb 20, 2025, 7:20AM
Needham Reiterates Buy on Ionis Pharmaceutica...
Benzinga Newsdesk - Feb 20, 2025, 5:01AM

Wednesday, February 19, 2025

Ionis Pharmaceuticals Q4 Revenue Growth Exceeds Guidance, Forecasts Over $600 Million In 2025 Sales
Vandana Singh - Feb 19, 2025, 12:11PM
Ionis Pharmaceuticals shares are trading high...
Benzinga Newsdesk - Feb 19, 2025, 10:20AM
Ionis Pharmaceuticals Forecasts 2025 Revenue ...
Benzinga Newsdesk - Feb 19, 2025, 7:05AM
Ionis Pharmaceuticals Q4 2024 GAAP EPS $(0.66...
Benzinga Newsdesk - Feb 19, 2025, 7:01AM
Earnings Scheduled For February 19, 2025
Benzinga Insights - Feb 19, 2025, 3:32AM

Wednesday, January 15, 2025

The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 5 Experts
Benzinga Insights - Jan 15, 2025, 4:01PM
RBC Capital Reiterates Outperform on Ionis Ph...
Benzinga Newsdesk - Jan 15, 2025, 9:57AM

Tuesday, January 07, 2025

Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected
Vandana Singh - Jan 7, 2025, 12:48PM

Friday, January 03, 2025

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic
Vandana Singh - Jan 3, 2025, 1:08PM

Friday, December 20, 2024

The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts
Benzinga Insights - Dec 20, 2024, 9:01AM
FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood
Vandana Singh - Dec 20, 2024, 7:24AM
Needham Maintains Buy on Ionis Pharmaceutical...
Benzinga Newsdesk - Dec 20, 2024, 7:18AM
Ionis Pharmaceuticals' TRYNGOLZA (olezarsen) ...
Benzinga Newsdesk - Dec 20, 2024, 3:15AM

Thursday, December 19, 2024

Trading Halt: Halt status updated at 6:55:00 ...
Benzinga Newsdesk - Dec 19, 2024, 6:55PM
Trading Halt: Halted at 4:28:30 p.m. ET - Tra...
Benzinga Newsdesk - Dec 19, 2024, 4:28PM

Friday, November 15, 2024

Shares of pharmaceutical and healthcare stock...
Benzinga Newsdesk - Nov 15, 2024, 3:21PM

Thursday, November 14, 2024

Piper Sandler Maintains Overweight on Ionis P...
Benzinga Newsdesk - Nov 14, 2024, 9:15AM

Tuesday, November 12, 2024

10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights - Nov 12, 2024, 12:35PM

Thursday, November 07, 2024

A Glimpse Into The Expert Outlook On Ionis Pharmaceuticals Through 5 Analysts
Benzinga Insights - Nov 7, 2024, 11:01AM
Wells Fargo Maintains Overweight on Ionis Pha...
Benzinga Newsdesk - Nov 7, 2024, 10:20AM
Where Ionis Pharmaceuticals Stands With Analysts
Benzinga Insights - Nov 7, 2024, 8:01AM
Needham Reiterates Buy on Ionis Pharmaceutica...
Benzinga Newsdesk - Nov 7, 2024, 5:19AM

Wednesday, November 06, 2024

Ionis Pharmaceuticals shares are trading high...
Benzinga Newsdesk - Nov 6, 2024, 9:11AM
Ionis Pharmaceuticals Q3 2024 Adj EPS $(0.72)...
Benzinga Newsdesk - Nov 6, 2024, 7:24AM
Ionis Pharmaceuticals Announced The Pivotal P...
Benzinga Newsdesk - Nov 6, 2024, 7:06AM

Monday, November 04, 2024

Ionis Announces FDA Acceptance Of New Drug Ap...
Benzinga Newsdesk - Nov 4, 2024, 9:46AM

Thursday, October 31, 2024

Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Chris Katje - Oct 31, 2024, 3:23PM

Monday, October 21, 2024

Ionis And AstraZeneca's WAINZUA Recommended F...
Benzinga Newsdesk - Oct 21, 2024, 2:53AM

Wednesday, October 09, 2024

Guggenheim Maintains Buy on Ionis Pharmaceuti...
Benzinga Newsdesk - Oct 9, 2024, 1:15PM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved